Adverse impact of a high<scp>CD4</scp>/<scp>CD8</scp>ratio in the allograft may be overcome by methotrexate‐ but not mycophenolate‐ or post‐transplant cyclophosphamide‐based graft versus host disease prophylaxis
Alexander Nikoloudis(Johannes Kepler University of Linz), Johannes Clausen(Johannes Kepler University of Linz), Sigrid Machherndl‐Spandl(Krankenhaus der Elisabethinen), Christoph Aichinger(Krankenhaus der Elisabethinen), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern), Emine Kaynak(Krankenhaus der Elisabethinen), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Robert Milanov(Krankenhaus der Elisabethinen), Michaela Binder(Durham University), Irene Straßl(Krankenhaus der Elisabethinen), Dagmar Wipplinger(Krankenhaus der Elisabethinen), A. Weltermann, Petra Hasengruber(Krankenhaus der Elisabethinen), Olga Stiefel(Krankenhaus der Elisabethinen)
Cited by 5
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523